Diffuse Bio, a leading provider of AI and experimental platforms for designing and screening protein therapeutics, today announced significant enhancements to DiffuseSandbox, its self-serve protein ...

Dash Bio, the bioanalysis CRO redefining speed in drug development, announced it has moved into a new 24,000 square foot ...

By adding AI-enabled RNA design and active learning, Eclipsebio extends its sequencing-based analytics platform into a fully ...

Eclipsebio has acquired Terrain Bio, a techbio company specializing in AI/ML RNA design and manufacturing analytics.

In 2025, Geekvape and Geek Bar achieved a major breakthrough on the global design stage, driven by years of deep investment in design capability and systematic innovation. Together, the two brands won ...

Korro Bio (NASDAQ:KRRO) used its Analyst Day to outline the rationale and development plans for KRRO-121, an RNA-editing ...

Casio has confirmed the February 2026 launch of its second collaboration with Japanese fashion label White Mountaineering. The new model is called the Pro Trek PRW-B1000WM-1 and sits at the high end ...

The vaginal microbiota is shaped by bacterial access to specific nutritional resources, influencing health outcomes. This study uses a resource-based model supported by clinical data to identify key ...

AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.

Cabaletta Bio (CABA) advances engineered cell therapies for autoimmune disease; insider buying boosts confidence. Click here ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...